Van ECK Associates Corp Has $81,000 Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Van ECK Associates Corp trimmed its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 24.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,964 shares of the company’s stock after selling 626 shares during the quarter. Van ECK Associates Corp’s holdings in Doximity were worth $81,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. LRI Investments LLC acquired a new position in Doximity during the 1st quarter worth approximately $27,000. Farther Finance Advisors LLC increased its position in Doximity by 324.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after purchasing an additional 603 shares in the last quarter. Blue Trust Inc. increased its position in Doximity by 621.4% during the 2nd quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock worth $37,000 after purchasing an additional 1,193 shares in the last quarter. Quarry LP increased its position in Doximity by 101.2% during the 2nd quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after purchasing an additional 131,253 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new position in Doximity during the 1st quarter worth approximately $46,000. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Trading Down 8.9 %

DOCS opened at $52.88 on Thursday. The company’s fifty day moving average price is $42.48 and its two-hundred day moving average price is $33.68. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $61.75. The company has a market cap of $9.82 billion, a price-to-earnings ratio of 61.68, a PEG ratio of 5.08 and a beta of 1.30.

Analyst Ratings Changes

A number of research firms have weighed in on DOCS. Evercore ISI boosted their target price on shares of Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Canaccord Genuity Group lowered shares of Doximity from a “buy” rating to a “hold” rating and boosted their target price for the stock from $40.00 to $60.00 in a report on Wednesday. Needham & Company LLC raised shares of Doximity from a “hold” rating to a “buy” rating and set a $38.00 target price on the stock in a report on Friday, August 9th. KeyCorp raised shares of Doximity from a “sector weight” rating to an “overweight” rating and set a $70.00 target price on the stock in a report on Friday, November 8th. Finally, Robert W. Baird boosted their target price on shares of Doximity from $41.00 to $45.00 and gave the stock an “outperform” rating in a report on Tuesday, September 17th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Doximity presently has a consensus rating of “Hold” and a consensus price target of $48.14.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.